Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence

Betsy Sleath1 Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, USA;2 Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, Chapel Hill, USACorrespondence[email protected]

Delesha M Carpenter1 Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Susan J Blalock1 Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Scott A Davis1 Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Ryan P Hickson1 Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Charles Lee3 Polyglot Systems, Inc., Morrisville, USA

Stefanie P Ferreri4 Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy, Chapel Hill, USA

Jennifer E Scott5 Consortium for Implementation Science, Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, USA

Lisa B Rodebaugh6 Department of Family Medicine, Brody School of Medicine, East Carolina University, Greenville, USA

Doyle M Cummings6 Department of Family Medicine, Brody School of Medicine, East Carolina University, Greenville, USA;7 Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, NC, USA

show all

Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence

Table 1 Patient characteristics (N=51)

Table 2 Patient responses on the diabetes medication self-efficacy scale (N=51)

Table 3 Multivariable linear regression results predicting the number of patient-reported problems in using their diabetes medications (N=51)

Table 4 Multivariable logistic regression results predicting whether the patients scored as having high/medium adherence on the Morisky adherence scale (N=51)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence

Figures & data

Table 1 Patient characteristics (N=51)

Table 2 Patient responses on the diabetes medication self-efficacy scale (N=51)

Table 3 Multivariable linear regression results predicting the number of patient-reported problems in using their diabetes medications (N=51)

Table 4 Multivariable logistic regression results predicting whether the patients scored as having high/medium adherence on the Morisky adherence scale (N=51)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date